×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
OS03: Expedited Approval Systems to Accelerate Patient Access to Innovative Drugs in Japan and the US
Session Chair(s)
Kanji Hirai, RPh
Director, Regulatory Policy & Intelligence, Regulatory Affair Area, Japan Dvlpmt
MSD K.K., Japan
Speaker(s)
Geet Mankad
MSD K.K., Japan
Director, Global Regulatory Affairs
Ryo Muto
Daiichi Sankyo Co., Ltd., Japan
Associate Director, Regulatory Affairs Oncology
Yoko Aoi, PhD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Deputy Review Director, Office of New Drug V
Have an account?